On November 15, 2023 Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company") a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd. ("Beyond Cancer")), reported that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in a fireside discussion and one-on-one meetings at the Piper Sandler Healthcare Conference being held November 28-30, 2023 in New York City (Press release, Beyond Air, NOV 15, 2023, View Source [SID1234637714]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Fireside Discussion Details:
Title: Beyond Air (NASDAQ: XAIR) Fireside Discussion
Date: Thursday, November 30th at 12:30 – 12:55 ET
Participants: Steve Lisi, Chairman & CEO, Beyond Air
Webcast: View Source;tp_key=683298e479
If you are interested in requesting a one-on-one meeting at the conference, please contact your Piper Sandler representative.